These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15863141)

  • 41. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
    Porter TR; Richards FM; Houlston RS; Evans DG; Jankowski JA; Macdonald F; Norbury G; Payne SJ; Fisher SA; Tomlinson I; Maher ER
    Oncogene; 2002 Mar; 21(12):1928-33. PubMed ID: 11896626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
    Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
    Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma.
    Holley SL; Matthias C; Jahnke V; Fryer AA; Strange RC; Hoban PR
    Oral Oncol; 2005 Feb; 41(2):156-60. PubMed ID: 15695117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
    Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of obesity and HER-2 polymorphisms as risk factors for endometrial cancer in Korean women.
    Tong SY; Ha SY; Ki KD; Lee JM; Lee SK; Lee KB; Kim MK; Cho CH; Kwon SY
    BJOG; 2009 Jul; 116(8):1046-52. PubMed ID: 19438491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2006 Jul; 42(6):607-13. PubMed ID: 16488657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The association of cyclin D1 (A870G) polymorphism with susceptibility to esophageal and cardiac cancer in north Chinese population].
    Wang R; Zhang JH; Li Y; Wen DG; He M; Wei LZ
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1089-92. PubMed ID: 12899785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: a high risk area.
    Hussain S; M Y; Thakur N; Salam I; Singh N; Mir MM; Bhat MA; Siddiqi MA; Das BC; Bharadwaj M
    Mol Carcinog; 2011 Jul; 50(7):487-98. PubMed ID: 21268129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer.
    Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Voigt LF; Chen C
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2524-30. PubMed ID: 16284373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.
    Yi YC; Chen MK; Chen LY; Ho ES; Ying TH; Wang PH; Yang SF
    Clin Chim Acta; 2009 Nov; 409(1-2):127-31. PubMed ID: 19758569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
    Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of CCND1 genotype and smoking habit in Taiwan lung cancer patients.
    Hsia TC; Liu CJ; Lin CH; Chang WS; Chu CC; Hang LW; Lee HZ; Lo WC; Bau DT
    Anticancer Res; 2011 Oct; 31(10):3601-5. PubMed ID: 21965784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450 1A1, cigarette smoking, and risk of endometrial cancer (United States).
    McGrath M; Hankinson SE; De Vivo I
    Cancer Causes Control; 2007 Dec; 18(10):1123-30. PubMed ID: 17717632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas.
    Gazioglu NM; Erensoy N; Kadioglu P; Sayitoglu MA; Ersoy IH; Hatirnaz O; Kisacik B; Oz B; Sar M; Ozbek U; Ciplak N; Cagatay P
    Med Sci Monit; 2007 Oct; 13(10):CR457-63. PubMed ID: 17901853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study.
    Sameer AS; Parray FQ; Dar MA; Nissar S; Banday MZ; Rasool S; Gulzar GM; Chowdri NA; Siddiqi MA
    Mol Med Rep; 2013 Mar; 7(3):811-5. PubMed ID: 23354584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study.
    Zhu H; Yang L; Zhou B; Yu R; Tang N; Wang B
    Carcinogenesis; 2006 Dec; 27(12):2491-6. PubMed ID: 16829688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.